View Cart  

U.S. FDA Plans Guidance on Device Enhancement versus Recall

The U.S. Food and Drug Administration (FDA) plans to issue clarifying guidance to address confusion among devicemakers about what exactly constitutes an enhancement and what qualifies as a recall, an FDA official says.

To View This Article:


Subscribe To International Medical Device Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00